Schedule 13G ownership disclosure

Corcept Therapeutics Inc

Security class unavailable · CUSIP: 218352102

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,996,149
Percent of class
10.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-017831
Form type
SC 13G/A
Filer
CORCEPT THERAPEUTICS INC
CIK
CIK 1088856
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub